메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 25, Issue 30, 2007, Pages 4855-
Genotype-based methods for anticipating gemcitabine-related severe toxicities may lead to false-negative results [5]
Author keywords

[No Author keywords available]
Indexed keywords

CAPECITABINE; CYTIDINE DEAMINASE; GEMCITABINE; PLATINUM DERIVATIVE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; RIBONUCLEOTIDE REDUCTASE;
EID: 36048964532     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.13.3918     Document Type: Letter
Times cited : (16)
References (7)
  • 1
    • 34447303456 scopus 로고    scopus 로고
    • Pharmacokinetics of gemcitabine in Japanese cancer patients: The impact of a cytidine deaminase polymorphism
    • Sugiyama E, Kaniwa N, Kim SR, et al: Pharmacokinetics of gemcitabine in Japanese cancer patients: The impact of a cytidine deaminase polymorphism. J Clin Oncol 25:32-42, 2007
    • (2007) J Clin Oncol , vol.25 , pp. 32-42
    • Sugiyama, E.1    Kaniwa, N.2    Kim, S.R.3
  • 2
    • 20244364241 scopus 로고    scopus 로고
    • Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin
    • Yonemori K, Ueno H, Okusaka T, et al: Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin. Clin Cancer Res 11:2620-2624, 2005
    • (2005) Clin Cancer Res , vol.11 , pp. 2620-2624
    • Yonemori, K.1    Ueno, H.2    Okusaka, T.3
  • 3
    • 0025978216 scopus 로고
    • A phase I clinical, plasma, and cellular pharmacology of gemcitabine
    • Abbruzzese JL, Grunewald R, Weeks RA, et al: A phase I clinical, plasma, and cellular pharmacology of gemcitabine. J Clin Oncol 9:491-498, 1991
    • (1991) J Clin Oncol , vol.9 , pp. 491-498
    • Abbruzzese, J.L.1    Grunewald, R.2    Weeks, R.A.3
  • 4
    • 34648847288 scopus 로고    scopus 로고
    • Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase down regulation
    • Mercier C, Raynal C, Dahan L, et al: Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase down regulation. Pharmacogenetics 17:841-844, 2007
    • (2007) Pharmacogenetics , vol.17 , pp. 841-844
    • Mercier, C.1    Raynal, C.2    Dahan, L.3
  • 5
    • 0031961050 scopus 로고    scopus 로고
    • Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro
    • Kirch HC, Schroder J, Hoppe H, et al: Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro. Exp Hematol 26:421-425, 1998
    • (1998) Exp Hematol , vol.26 , pp. 421-425
    • Kirch, H.C.1    Schroder, J.2    Hoppe, H.3
  • 6
    • 0345628622 scopus 로고    scopus 로고
    • Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemia
    • Schroder JK, Kirch C, Seeber S, et al: Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemia. Br J Haematol 103:1096-1103, 1998
    • (1998) Br J Haematol , vol.103 , pp. 1096-1103
    • Schroder, J.K.1    Kirch, C.2    Seeber, S.3
  • 7
    • 33645692656 scopus 로고    scopus 로고
    • Gemcitabine pharmacogenomics: Cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics
    • Gilbert JA, Salavaggione OE, Ji Y, et al: Gemcitabine pharmacogenomics: Cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics. Clin Cancer Res 12:1794-1803, 2006
    • (2006) Clin Cancer Res , vol.12 , pp. 1794-1803
    • Gilbert, J.A.1    Salavaggione, O.E.2    Ji, Y.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.